PXN and prostate adenocarcinoma: We found that PXN expression was upregulated in human tumors (cholangiocarcinoma, esophageal carcinoma, GBM, HNSC, LIHC, thyroid carcinoma, PRAD, stomach adenocarcinoma, and kidney chromophobe) compared with corresponding normal tissues.